Nucleocapsid serum antigen determination in SARS-CoV-2 infected patients using the single molecule array technology and prediction of disease severity

Julien Favresse; Jean-Louis Bayart; Clara David; Jean-Michel Dogné; Jonathan Douxfils

doi:10.1016/j.jinf.2022.01.023

Nucleocapsid serum antigen determination in SARS-CoV-2 infected patients using the single molecule array technology and prediction of disease severity

Julien Favresse, Jean-Louis Bayart, Clara David, Jean-Michel Dogné, Jonathan Douxfils

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	e4-e6
Journal	Journal of Infection
Volume	84
Issue number	4
Early online date	2022
DOIs	https://doi.org/10.1016/j.jinf.2022.01.023
Publication status	Published - Apr 2022

Keywords

Antigenic assay
COVID-19
disease severity
RT-PCR
SARS-CoV-2

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jinf.2022.01.023

Cite this

@article{707143c750124c16aac2267f91be8e69,

title = "Nucleocapsid serum antigen determination in SARS-CoV-2 infected patients using the single molecule array technology and prediction of disease severity",

keywords = "Antigenic assay, COVID-19, disease severity, RT-PCR, SARS-CoV-2",

author = "Julien Favresse and Jean-Louis Bayart and Clara David and Jean-Michel Dogn{\'e} and Jonathan Douxfils",

note = "Funding Information: The authors would like to thank the technical teams from the laboratories of QUALIblood, Clinique Saint-Luc Bouge and Clinique Saint-Pierre Ottignies for collecting the samples and performing the analyses.",

year = "2022",

month = apr,

doi = "10.1016/j.jinf.2022.01.023",

language = "English",

volume = "84",

pages = "e4--e6",

journal = "Journal of Infection",

issn = "0163-4453",

publisher = "Elsevier",

number = "4",

}

TY - JOUR

T1 - Nucleocapsid serum antigen determination in SARS-CoV-2 infected patients using the single molecule array technology and prediction of disease severity

AU - Favresse, Julien

AU - Bayart, Jean-Louis

AU - David, Clara

AU - Dogné, Jean-Michel

AU - Douxfils, Jonathan

N1 - Funding Information: The authors would like to thank the technical teams from the laboratories of QUALIblood, Clinique Saint-Luc Bouge and Clinique Saint-Pierre Ottignies for collecting the samples and performing the analyses.

PY - 2022/4

Y1 - 2022/4

KW - Antigenic assay

KW - COVID-19

KW - disease severity

KW - RT-PCR

KW - SARS-CoV-2

UR - http://www.scopus.com/inward/record.url?scp=85127736876&partnerID=8YFLogxK

U2 - 10.1016/j.jinf.2022.01.023

DO - 10.1016/j.jinf.2022.01.023

M3 - Article

C2 - 35074508

SN - 0163-4453

VL - 84

SP - e4-e6

JO - Journal of Infection

JF - Journal of Infection

IS - 4

ER -

Nucleocapsid serum antigen determination in SARS-CoV-2 infected patients using the single molecule array technology and prediction of disease severity

Keywords

UN SDGs

Access to Document

Other files and links

Clinical Pharmacology Research Group

The COVILAB project : Clinical laboratory investigations related to COVID-19

Cite this

Nucleocapsid serum antigen determination in SARS-CoV-2 infected patients using the single molecule array technology and prediction of disease severity

Keywords

UN SDGs

Access to Document

Other files and links

Projects

Clinical Pharmacology Research Group

The COVILAB project : Clinical laboratory investigations related to COVID-19

Cite this